ZME Science on MSN2d
New study using CRISPR technology reveals a way to make tomatoes sweeter without sacrificing yield.
The world produces around 180 million tons of tomatoes each year. Whether they are raw, cooked, or used in sauces, tomatoes ...
New tool allows researchers to study gene mutation directly within living human cells
Gene mutations have consequences both good and bad—from resistance to conditions like diabetes to susceptibility to certain ...
Gene-edited tomatoes achieve increased sweetness without loss of size or yield
I n a groundbreaking study published in the journal Nature, researchers have successfully used gene editing to create sweeter ...
Chemistry World2d
Tomato sweetness boosted by gene editing to knock out two genes
Genetically editing sugar-regulating genes increases tomato sweetness, without affecting yield or size. The findings break a ...
New Scientist3d
Sweeter tomatoes are coming soon thanks to CRISPR gene editing
Selection for bigger tomatoes has made the fruits less sweet, but now it has been shown that gene editing can make them ...
GEN3d
Combining Base and Prime Editing to Decipher Which Gene Variants Lead to Cancer
Researchers at ETH Zurich combined two CRISPR-Cas methods to decipher how mutations in a cell’s genome affect its function.
Yahoo Finance2d
Breakthrough Research Presented in Scientific Reports Demonstrates How Gene-Edited Microbes Offer a New Source of Nitrogen to Farmers
The study, a collaboration of researchers from the University of Wisconsin-Madison, Purdue University, and Pivot Bio, a ...
Using CRISPR to decipher whether gene variants lead to cancer
In recent years, scientists have created a range of new methods based on CRISPR-Cas technology for precisely editing the ...
BioPharma Dive11d
Sickle cell patient dies in Beam study of base editing therapy
The death, which investigators linked to a preparatory chemo treatment rather than Beam's medicine, highlights the risks of using decades-old transplant drugs alongside cutting-edge CRISPR medicines.
Beam stock rebounds as Leerink upgrades despite fatality in gene editing trial
Beam Therapeutics (BEAM) stock gains as Leerink upgrades the biotech despite a fatality in a gene editing study, citing an ...
News Medical on MSN1d
Scientists map cancer mutations in EGFR gene, revealing drug resistance paths
Researchers used base and prime editing to uncover new EGFR gene mutations that affect cancer progression and drug resistance ...